Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders
Tianyun Wang,Kendra Hoekzema,Davide Vecchio,Huidan Wu,Arvis Sulovari,Bradley P Coe,Madelyn A Gillentine,Amy B Wilfert,Luis A Perez-Jurado,Malin Kvarnung,Yoeri Sleyp,Rachel K Earl,Jill A Rosenfeld,Madeleine R Geisheker,Lin Han,Bing Du,Chris Barnett,Elizabeth Thompson,Marie Shaw,Renee Carroll,Kathryn Friend,Rachael Catford,Elizabeth E Palmer,Xiaobing Zou,Jianjun Ou,Honghui Li,Hui Guo,Jennifer Gerdts,Emanuela Avola,Giuseppe Calabrese,Maurizio Elia,Donatella Greco,Anna Lindstrand,Ann Nordgren,Britt-Marie Anderlid,Geert Vandeweyer,Anke Van Dijck,Nathalie Van der Aa,Brooke McKenna,Miroslava Hancarova,Sarka Bendova,Marketa Havlovicova,Giovanni Malerba,Bernardo Dalla Bernardina,Pierandrea Muglia,Arie van Haeringen,Mariette J V Hoffer,Barbara Franke,Gerarda Cappuccio,Martin Delatycki,Paul J Lockhart,Melanie A Manning,Pengfei Liu,Ingrid E Scheffer,Nicola Brunetti-Pierri,Nanda Rommelse,David G Amaral,Gijs W E Santen,Elisabetta Trabetti,Zdeněk Sedláček,Jacob J Michaelson,Karen Pierce,Eric Courchesne,R Frank Kooy,SPARK Consortium,Magnus Nordenskjöld,Corrado Romano,Hilde Peeters,Raphael A Bernier,Jozef Gecz,Kun Xia,Evan E Eichler,John Acampado,Andrea J Ace,Alpha Amatya,Irina Astrovskaya,Asif Bashar,Elizabeth Brooks,Martin E Butler,Lindsey A Cartner,Wubin Chin,Wendy K Chung,Amy M Daniels,Pamela Feliciano,Chris Fleisch,Swami Ganesan,William Jensen,Alex E Lash,Richard Marini,Vincent J Myers,Eirene O'Connor,Chris Rigby,Beverly E Robertson,Neelay Shah,Swapnil Shah,Emily Singer,LeeAnne G Snyder,Alexandra N Stephens,Jennifer Tjernagel,Brianna M Vernoia,Natalia Volfovsky,Loran Casey White,Alexander Hsieh,Yufeng Shen,Xueya Zhou,Tychele N Turner,Ethan Bahl,Taylor R Thomas,Leo Brueggeman,Tanner Koomar,Brian J O'Roak,Rebecca A Barnard,Richard A Gibbs,Donna Muzny,Aniko Sabo,Kelli L Baalman Ahmed,Matthew Siegel,Leonard Abbeduto,Brittani A Hilscher,Deana Li,Kaitlin Smith,Samantha Thompson,Charles Albright,Eric M Butter,Sara Eldred,Nathan Hanna,Mark Jones,Daniel Lee Coury,Jessica Scherr,Taylor Pifher,Erin Roby,Brandy Dennis,Lorrin Higgins,Melissa Brown,Michael Alessandri,Anibal Gutierrez,Melissa N Hale,Lynette M Herbert,Hoa Lam Schneider,Giancarla David,Robert D Annett,Dustin E Sarver,Ivette Arriaga,Alexies Camba,Amanda C Gulsrud,Monica Haley,James T McCracken,Sophia Sandhu,Maira Tafolla,Wha S Yang,Laura A Carpenter,Catherine C Bradley,Frampton Gwynette,Patricia Manning,Rebecca Shaffer,Carrie Thomas,Emily A Fox,Jennifer A Gerdts,Micah Pepper,Theodore Ho,Daniel Cho,Joseph Piven,Holly Lechniak,Latha V Soorya,Rachel Gordon,Allison Wainer,Lisa Yeh,Cesar Ochoa-Lubinoff,Nicole Russo,Elizabeth Berry-Kravis,Stephanie Booker,Craig A Erickson,Lisa M Prock,Katherine G Pawlowski,Emily T Matthews,Stephanie J Brewster,Margaret A Hojlo,Evi Abada,Elena Lamarche,Shwetha C Murali,William T Harvey,Hannah E Kaplan,Karen L Pierce,Lindsey DeMarco,Susannah Horner,Juhi Pandey,Samantha Plate,Mustafa Sahin,Katherine D Riley,Erin Carmody,Julia Constantini,Amy Esler,Ali Fatemi,Hanna Hutter,Rebecca J Landa,Alexander P McKenzie,Jason Neely,Vini Singh,Bonnie Van Metre,Ericka L Wodka,Eric J Fombonne,Lark Y Huang-Storms,Lillian D Pacheco,Sarah A Mastel,Leigh A Coppola,Sunday Francis,Andrea Jarrett,Suma Jacob,Natasha Lillie,Jaclyn Gunderson,Dalia Istephanous,Laura Simon,Ori Wasserberg,Angela L Rachubinski,Cordelia R Rosenberg,Stephen M Kanne,Amanda D Shocklee,Nicole Takahashi,Shelby L Bridwell,Rebecca L Klimczac,Melissa A Mahurin,Hannah E Cotrell,Cortaiga A Grant,Samantha G Hunter,Christa Lese Martin,Cora M Taylor,Lauren K Walsh,Katherine A Dent,Andrew Mason,Anthony Sziklay,Christopher J Smith
DOI: https://doi.org/10.1038/s41467-020-18723-y
2020-10-01
Abstract:Most genes associated with neurodevelopmental disorders (NDDs) were identified with an excess of de novo mutations (DNMs) but the significance in case-control mutation burden analysis is unestablished. Here, we sequence 63 genes in 16,294 NDD cases and an additional 62 genes in 6,211 NDD cases. By combining these with published data, we assess a total of 125 genes in over 16,000 NDD cases and compare the mutation burden to nonpsychiatric controls from ExAC. We identify 48 genes (25 newly reported) showing significant burden of ultra-rare (MAF < 0.01%) gene-disruptive mutations (FDR 5%), six of which reach family-wise error rate (FWER) significance (p < 1.25E-06). Among these 125 targeted genes, we also reevaluate DNM excess in 17,426 NDD trios with 6,499 new autism trios. We identify 90 genes enriched for DNMs (FDR 5%; e.g., GABRG2 and UIMC1); of which, 61 reach FWER significance (p < 3.64E-07; e.g., CASZ1). In addition to doubling the number of patients for many NDD risk genes, we present phenotype-genotype correlations for seven risk genes (CTCF, HNRNPU, KCNQ3, ZBTB18, TCF12, SPEN, and LEO1) based on this large-scale targeted sequencing effort.